Although all BRAFi efficiently impeded ERK phosphorylation in BRAF-mutant and BRAF-WT melanoma cells, their effect on MAPK signaling in endothelial cells resembled the effect in melanoma cells with upstream NRAS mutations (Fig S1). This evidence concerns the gene NRAS and melanoma.